These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2565213)

  • 1. Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.
    Lim WH; Hooper WD
    Drug Metab Dispos; 1989; 17(2):212-7. PubMed ID: 2565213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative studies of methylphenobarbital metabolism in man.
    Hooper WD; Kunze HE; Eadie MJ
    Drug Metab Dispos; 1981; 9(4):381-5. PubMed ID: 6114839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective binding of mephobarbital to plasma proteins.
    O'Shea NJ; Hooper WD
    Chirality; 1990; 2(4):257-62. PubMed ID: 2083148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans.
    Kobayashi K; Morita J; Chiba K; Wanibuchi A; Kimura M; Irie S; Urae A; Ishizaki T
    Pharmacogenetics; 2004 Aug; 14(8):549-56. PubMed ID: 15284537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of prenylamine racemate and enantiomers in man.
    Paar WD; Brockmeier D; Hirzebruch M; Schmidt EK; von Unruh GE; Dengler HJ
    Arzneimittelforschung; 1990 Jun; 40(6):657-61. PubMed ID: 2397000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
    Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
    Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.
    Wedlund PJ; Aslanian WS; Jacqz E; McAllister CB; Branch RA; Wilkinson GR
    J Pharmacol Exp Ther; 1985 Sep; 234(3):662-9. PubMed ID: 4032286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of reboxetine enantiomers in the dog.
    Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
    Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients.
    Alshowaier IA; el-Yazigi A; Ezzat A; Abd el-Warith A; Nicholls PJ
    J Clin Pharmacol; 1999 Nov; 39(11):1136-42. PubMed ID: 10579143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man.
    Brode E; Müller-Peltzer H; Hollmann M
    Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):717-27. PubMed ID: 3221745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of sotalol enantiomers in humans.
    Carr RA; Foster RT; Lewanczuk RZ; Hamilton PG
    J Clin Pharmacol; 1992 Dec; 32(12):1105-9. PubMed ID: 1487548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective pharmacokinetics of oxprenolol and its glucuronides in humans.
    Laethem ME; Lefebvre RA; Belpaire FM; Vanhoe HL; Bogaert MG
    Clin Pharmacol Ther; 1995 Apr; 57(4):419-24. PubMed ID: 7712670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study.
    Egginger G; Lindner W; Kahr S; Stoschitzky K
    Chirality; 1993; 5(7):505-12. PubMed ID: 8240927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of methylphenobarbital in man.
    Hooper WD; Kunze HE; Eadie MJ
    Ther Drug Monit; 1981; 3(1):39-44. PubMed ID: 7233487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
    Główka FK; Caldwell J
    Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
    García Quetglas E; Azanza JR; Cardenas E; Sádaba B; Campanero MA
    Biopharm Drug Dispos; 2007 Jan; 28(1):19-33. PubMed ID: 17061296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective pharmacokinetics and metabolism of flobufen in guinea pigs.
    Trejtnar F; Král R; Pávek P; Wsól V
    Chirality; 2003 Oct; 15(8):724-9. PubMed ID: 12923810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.